Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer

Brian P Riesenberg1, Elizabeth G Hunt1,2, Megan D Tennant3

  • 1Immunotherapy Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Cancer Research
|September 20, 2022
PubMed

Insights

Protein translation is repressed in T cells within solid tumors, impairing antitumor immunity. Enhancing T-cell metabolism and proteasome activity can restore protein synthesis, boosting immune responses against cancer.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Protein synthesis is crucial for effective immune responses.
  • The tumor microenvironment (TME) presents stressors like nutrient competition that can inhibit T cell function.
  • Understanding how T cell protein translation is affected in the TME is vital for improving cancer immunotherapy.

Purpose of the Study:

  • To investigate the impact of the TME on T cell protein translation.
  • To identify mechanisms regulating T cell protein translation in solid tumors.
  • To explore therapeutic strategies to enhance T cell function in cancer.

Main Methods:

  • Analysis of human and mouse tumors to assess T cell protein translation.
  • Utilizing genetic mouse models to study the role of the unfolded protein response (UPR) element eIF2α.
  • Employing metabolic and pharmacological approaches to modulate T cell function and proteasome activity.

Main Results:

  • Protein translation is significantly repressed in T cells within solid tumors.
  • Reduced glucose in the TME activates the UPR element eIF2α (eukaryotic translation initiation factor 2 alpha), leading to translation attenuation.
  • Activated p-eIF2α impairs T cell-mediated tumor suppression.
  • Reprogramming T cell metabolism and enhancing proteasome activity alleviate p-eIF2α accumulation and restore protein translation.
  • These interventions support sustained cytokine synthesis and optimal antitumor T cell function.

Conclusions:

  • T cell protein translation is a critical target in the TME.
  • The UPR, mediated by eIF2α, plays a key role in suppressing T cell function in tumors.
  • Metabolic reprogramming and proteasome modulation represent promising therapeutic strategies to enhance T cell-based cancer immunotherapy.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
58
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K